Physician profile
Patrick Lawrence Maher
NPI 1134501463
$10,451.08
in general payments reported to CMS, 2019-2025
9 companies · $571 in 2025
The $571 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $125 · 2021: $915 · 2022: $4,528 · 2023: $2,786 · 2024: $1,197 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,344 · Food and Beverage: $2,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,344.47 |
| Food and Beverage | $2,209.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,782.34 | 2021-2025 | Mako, Gamma, Triathlon |
| Smith+Nephew, INC. | $4,207.37 | 2022-2025 | Tandem, Ri Hip Navigation, Or3o Dual Mobility |
| Medical Device Business Services, INC. | $1,169.97 | 2019-2022 | |
| Depuy Synthes Sales INC. | $127.09 | 2022 | |
| Kci USA, INC. | $74.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $35.33 | 2025 | Iovera |
| Invictus Surgical Incorporated | $21.81 | 2025 | |
| Summit Surgical Corp. | $17.83 | 2024 | |
| Trice Medical, INC. | $14.92 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.